Alejo Rodriguez-Vida

Alejo Rodriguez-Vida

UNVERIFIED PROFILE

Are you Alejo Rodriguez-Vida?   Register this Author

Register author
Alejo Rodriguez-Vida

Alejo Rodriguez-Vida

Publications by authors named "Alejo Rodriguez-Vida"

Are you Alejo Rodriguez-Vida?   Register this Author

23Publications

558Reads

48Profile Views

Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities.

Nat Rev Urol 2019 Jul;16(7):433-445

Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0183-5DOI Listing
July 2019

The Cancer Genome Atlas Project in Bladder Cancer.

Cancer Treat Res 2018;175:259-271

Medical Oncology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-93339-9_12DOI Listing
June 2019

Treatment of Metastatic Urothelial Cancer in 2018.

JAMA Oncol 2019 Jun;5(6):904-905

Medical Oncology Department, Hospital del Mar, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.0182DOI Listing
June 2019

Immunotherapy Combinations and Sequences in Urothelial Cancer: Facts and Hopes.

Clin Cancer Res 2018 12 10;24(24):6115-6124. Epub 2018 Jul 10.

Medical Oncology Department, Hospital del Mar, IMIM (Hospital del Mar Research Institute), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3108DOI Listing
December 2018

Avelumab for the treatment of urothelial cancer.

Expert Rev Anticancer Ther 2018 05 14;18(5):421-429. Epub 2018 Mar 14.

a Medical Oncology Department , Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar , Barcelona , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1448271DOI Listing
May 2018

New treatment options for metastatic renal cell carcinoma.

ESMO Open 2017 9;2(2):e000185. Epub 2017 May 9.

Medical Oncology Department, Algemeen Ziekenhuis Klina, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519813PMC
May 2017

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma.

ESMO Open 2016 25;1(3):e000013. Epub 2016 May 25.

Texas Oncology-Baylor Charles A Sammons Cancer Center , Dallas, Texas , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070260PMC
May 2016

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Drug Des Devel Ther 2015 29;9:3325-39. Epub 2015 Jun 29.

Medical Oncology Department, San Camillo and Forlanini Hospitals, Rome, Italy.

View Article

Download full-text PDF

Source
http://www.dovepress.com/enzalutamide-for-the-treatment-of-m
Publisher Site
http://dx.doi.org/10.2147/DDDT.S69433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492664PMC
March 2016

Is there an antiandrogen withdrawal syndrome with enzalutamide?

BJU Int 2015 Mar 24;115(3):373-80. Epub 2014 Oct 24.

Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12826
Publisher Site
http://dx.doi.org/10.1111/bju.12826DOI Listing
March 2015

Precision medicine for prostate cancer.

Expert Rev Anticancer Ther 2014 Nov 30;14(11):1305-15. Epub 2014 Oct 30.

Department of Medical Oncology, Guy's Hospital, London, SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.972948DOI Listing
November 2014

Cytoreductive nephrectomy: past, present and future.

Expert Rev Anticancer Ther 2014 Mar 6;14(3):271-7. Epub 2014 Jan 6.

Department of Medical Oncology, Guy's Hospital, London, SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2014.864240DOI Listing
March 2014

Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer.

Eur J Cancer 2014 Mar 13;50(5):1042-3. Epub 2014 Jan 13.

The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.12.016DOI Listing
March 2014

Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?

BJU Int 2014 Mar;113(3):350-1

Department of Medical Oncology, Guy's Hospital, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bju.12493
Publisher Site
http://dx.doi.org/10.1111/bju.12493DOI Listing
March 2014

The role of metastasectomy in renal cell carcinoma.

Expert Rev Anticancer Ther 2013 Dec;13(12):1363-71

Department of Medical Oncology, Guy's Hospital, London, SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11934-012-0293
Web Search
http://www.tandfonline.com/doi/full/10.1586/14737140.2013.85
Publisher Site
http://dx.doi.org/10.1586/14737140.2013.856762DOI Listing
December 2013

Causes of death in men with prostate cancer: an analysis of 50,000 men from the Thames Cancer Registry.

BJU Int 2013 Jul;112(2):182-9

Department of Medical Oncology, Guy's Hospital, King's College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12212DOI Listing
July 2013